Authors
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
How to Determine ‘Good Science’ for Systematic Literature Reviews in Clinical Research and DevelopmentBest practices for assessing publications.
Latest:
Using Machine Learning to Predict Placebo Response and Increase Clinical Trial SuccessA look at the prevalence of placebo response in clinical trials and how advanced solutions can mitigate the risk it poses to drug development.
Latest:
Aligning Patient Burden with Planetary BurdenHow making trial participation easier can reduce the impact on the environment.
Latest:
How DCT Technology Can Enable Follow-up Clinical StudiesResearch can reveal vital information about treatments in the long run.
Latest:
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
Clinical Study Audits: The Quality Management ApproachAdvancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.
Latest:
Accelerating Clinical Trial Design and OperationsFully-integrated, component-based CDMS offers flexibility, customization, and efficiency.
Latest:
Transforming Clinical Event Adjudication in the Era of COVID-19There's no one-size-fits-all approach during the COVID-19 pandemic
Latest:
Where Do We Go From Here?Lessons from six months of conducting clinical trials during the COVID-19 pandemic
Latest:
Rethinking ECOG Scores to Improve Patient Access and Clinical Trials EligibilityRecent study results highlight need for new metrics in ECOG scoring to mitigate variability.
Latest:
How a Global Privacy Standard Can Boost Patient TrustRegulations that apply across geographic borders can provide researchers and patients a firmer foundation on data protection.
Latest:
Pivoting Toward Sustainable Supply Chains in Clinical ResearchAs clinical research continues to globalize and grow at pace, there is a risk that global greenhouse gas emissions will escalate unless mitigation strategies are actively included in corporate strategies.
Latest:
5 Ways DCTs Can Positively Impact Trial DiversityCOVID-19 forces life sciences industry to make long overdue changes.
Latest:
Advancing COPD Research: Harnessing Wearable Sensors and Remote Monitoring for Improved InsightsWearable sensors and remote monitoring technology can help HCPs monitor and manage COPD more effectively.
Latest:
Employing the Power of Bayesian Methods to Expedite LearningBayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.
Latest:
Clinical Trials Supply Chain: How to Respond to Recent TransformationsConcept of flexibility acting as driving force behind industry’s swift response to COVID-19.
Latest:
Optimizing Technology Implementation to Improve Diversity in Clinical ResearchThree key considerations for deploying technology to help increase diversity in trials.
Latest:
Towards Data-Driven Clinical Trial Planning and StrategyOptimizing feasibility through increased data collection.
Latest:
How to Address—and Overcome—Operational Challenges in Master Protocol StudiesTrials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
Latest:
What Patients Expect from Clinical Trials in the COVID-19 EraKey takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.
Latest:
Immunomodulators and Cancer ResearchDistinguishing CAR-T and CPI approaches and the clinical trial challenges and complexities associated with each.
Latest:
Three Ways to Leverage AI in Clinical Trials - Right NowThis eBook will discuss three key ways that researchers can implement AI to address data challenges, improve patient safety and outcomes, and accelerate processes.
Latest:
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
